| Target Price | $15.30 |
| Price | $5.98 |
| Potential |
155.85%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target Vir Biotechnology Inc 2026 .
The average Vir Biotechnology Inc target price is $15.30.
This is
155.85%
register free of charge
$32.55
444.31%
register free of charge
$12.12
102.68%
register free of charge
|
|
| A rating was issued by 14 analysts: 13 Analysts recommend Vir Biotechnology Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Vir Biotechnology Inc stock has an average upside potential 2026 of
155.85%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 74.21 | 11.13 |
| 13.89% | 85.00% | |
| EBITDA Margin | -743.66% | -4,427.89% |
| 6.28% | 495.42% | |
| Net Margin | -703.36% | -4,141.20% |
| 1.45% | 488.78% |
11 Analysts have issued a sales forecast Vir Biotechnology Inc 2025 . The average Vir Biotechnology Inc sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Vir Biotechnology Inc EBITDA forecast 2025. The average Vir Biotechnology Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 Vir Biotechnology Inc Analysts have issued a net profit forecast 2025. The average Vir Biotechnology Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -3.83 | -3.32 |
| 16.56% | 13.32% | |
| P/E | negative | |
| EV/Sales | 20.19 |
11 Analysts have issued a Vir Biotechnology Inc forecast for earnings per share. The average Vir Biotechnology Inc EPS is
This results in the following potential growth metrics and future valuations:
Vir Biotechnology Inc...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 15 2025 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Sep 03 2025 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Aug 27 2025 |
| Raymond James |
Locked
➜
Locked
|
Locked | Jul 11 2025 |
| Needham |
Locked
➜
Locked
|
Locked | May 22 2025 |
| Needham |
Locked
➜
Locked
|
Locked | May 12 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Apr 17 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 15 2025 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Sep 03 2025 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Aug 27 2025 |
|
Locked
Raymond James:
Locked
➜
Locked
|
Jul 11 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
May 22 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
May 12 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Apr 17 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


